FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

The New York Times – Business:

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.

This post first appeared in The New York Times – Business. Read the original article.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *